How Cryo-Em Advances Structural Biology

𝗖𝗿𝘆𝗼𝟮𝗦𝘁𝗿𝘂𝗰𝘁: 𝗔𝗜-𝗗𝗿𝗶𝘃𝗲𝗻 𝗗𝗲 𝗡𝗼𝘃𝗼 𝗣𝗿𝗼𝘁𝗲𝗶𝗻 𝗦𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗲 𝗠𝗼𝗱𝗲𝗹𝗶𝗻𝗴 𝗳𝗼𝗿 𝗖𝗿𝘆𝗼-𝗘𝗠  Building atomic protein structures from Cryo-EM density maps remains one of the biggest challenges in structural biology, especially in de novo modeling scenarios where no homologous structures are available. Enter Cryo2Struct—a fully automated AI-based method that leverages 3D transformers and Hidden Markov Models (HMMs) to predict atomic-level protein structures directly from Cryo-EM maps. 🔬 Key Innovations in Cryo2Struct 🔹 𝟯𝗗 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗲𝗿-𝗣𝗼𝘄𝗲𝗿𝗲𝗱 𝗔𝘁𝗼𝗺 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝗼𝗻 Cryo2Struct employs a deep learning model with an attention mechanism to accurately predict Cα, N, and C backbone atoms, as well as amino acid types, directly from Cryo-EM density maps. 🔹 𝗛𝗶𝗱𝗱𝗲𝗻 𝗠𝗮𝗿𝗸𝗼𝘃 𝗠𝗼𝗱𝗲𝗹 (𝗛𝗠𝗠)-𝗕𝗮𝘀𝗲𝗱 𝗕𝗮𝗰𝗸𝗯𝗼𝗻𝗲 𝗧𝗿𝗮𝗰𝗶𝗻𝗴 A customized Viterbi algorithm is used to connect predicted atoms into protein chains, aligning them with the input protein sequence to generate high-accuracy atomic structures. 🔹 𝗥𝗼𝗯𝘂𝘀𝘁 𝗔𝗴𝗮𝗶𝗻𝘀𝘁 𝗠𝗮𝗽 𝗥𝗲𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗩𝗮𝗿𝗶𝗮𝗯𝗶𝗹𝗶𝘁𝘆 Unlike traditional methods, Cryo2Struct is highly robust across varying Cryo-EM resolutions (1.9–4.0 Å), maintaining high accuracy in atomic modeling even with low-resolution maps. 🔹 𝗦𝘂𝗽𝗲𝗿𝗶𝗼𝗿 𝘁𝗼 𝗘𝘅𝗶𝘀𝘁𝗶𝗻𝗴 𝗗𝗲 𝗡𝗼𝘃𝗼 𝗠𝗼𝗱𝗲𝗹𝗶𝗻𝗴 𝗧𝗼𝗼𝗹𝘀 Compared to Phenix, one of the most widely used Cryo-EM modeling tools, Cryo2Struct achieves: ✅ 65% recall vs. 40% in Phenix for identifying correct Cα atoms ✅ Higher F1 score (66%) and TM-score (0.22) for overall model quality ✅ 2.6× more complete protein structures than Phenix, ensuring better model coverage 🚀 𝗪𝗵𝘆 𝗧𝗵𝗶𝘀 𝗠𝗮𝘁𝘁𝗲𝗿𝘀 𝗳𝗼𝗿 𝗦𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗮𝗹 𝗕𝗶𝗼𝗹𝗼𝗴𝘆 & 𝗔𝗜-𝗗𝗿𝗶𝘃𝗲𝗻 𝗣𝗿𝗼𝘁𝗲𝗶𝗻 𝗠𝗼𝗱𝗲𝗹𝗶𝗻𝗴 🔬 Faster & more accurate atomic model building without homologous templates 🧩 A breakthrough in de novo protein structure prediction using Cryo-EM ⚡ A step forward in AI-powered structure-based drug discovery & biomolecular engineering 💬 𝗪𝗵𝗮𝘁’𝘀 𝗻𝗲𝘅𝘁 𝗳𝗼𝗿 𝗔𝗜-𝗱𝗿𝗶𝘃𝗲𝗻 𝗖𝗿𝘆𝗼-𝗘𝗠 𝗺𝗼𝗱𝗲𝗹𝗶𝗻𝗴? 𝗖𝗼𝘂𝗹𝗱 𝗖𝗿𝘆𝗼𝟮𝗦𝘁𝗿𝘂𝗰𝘁 𝗽𝗮𝘃𝗲 𝘁𝗵𝗲 𝘄𝗮𝘆 𝗳𝗼𝗿 𝗳𝘂𝗹𝗹𝘆 𝗮𝘂𝘁𝗼𝗺𝗮𝘁𝗲𝗱 𝘀𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗲 𝗱𝗲𝘁𝗲𝗿𝗺𝗶𝗻𝗮𝘁𝗶𝗼𝗻? 𝗟𝗲𝘁’𝘀 𝗱𝗶𝘀𝗰𝘂𝘀𝘀! 🔗 Read the full paper here: https://lnkd.in/dKVRA7by #CryoEM #StructuralBiology #MachineLearning #ComputationalBiology #ProteinModeling #AIinScience #Bioinformatics #DeepLearning #DrugDiscovery #3DTransformers #HiddenMarkovModels

Published in Nature (June 2025), this technology feature explores how time-resolved cryo-electron microscopy (TR cryo-EM) is revolutionizing structural biology by capturing rapid protein movements at near-atomic resolution. 🔬 Key Highlights: • TR cryo-EM can visualize dynamic protein conformations on millisecond to microsecond timescales • Enables “freeze-frame” snapshots of enzymes, receptors, and molecular machines in action • Offers insights into druggable intermediate states often missed by traditional static methods ⚠️ However, its adoption is limited by the need for specialized equipment, complex workflows, and deep technical expertise. As this technology evolves, it holds enormous promise for unlocking new frontiers in protein dynamics, drug discovery, and molecular design. #CryoEM #StructuralBiology #ProteinDynamics #DrugDiscovery #Nature #MolecularMotion #LifeSciencesInnovation https://lnkd.in/dtAPSYw2 Figure Courtesy: Nature

For 50 years, a key protein behind heart disease, among the leading cause of death worldwide remained a scientific mystery. It was too large and complex for traditional methods; its structure was invisible to us. Now, researchers have combined cryo-electron microscopy with DeepMind's AlphaFold to reveal the atomic structure of that protein: apoB100, the very scaffold of "bad cholesterol." This marks a deeper shift in how we approach science.  When we can see biology at this level of detail, healthcare moves from managing symptoms to engineering interventions at the molecular root. AI starts to function as a new kind of microscope, one that reveals the invisible machinery of life and allows entirely new questions to be asked. This is the kind of progress that matters.     AI as an instrument for understanding, precision, and prevention. It’s a glimpse into a future where compute and science converge to tackle humanity’s hardest health challenges at their source.    Read the full story: https://lnkd.in/gbum2dKu #AIInHealthCare #AIForGood

🚀 After 50+ years of scientific detective work, we've finally unlocked the molecular "lock" that powers our cells: the structure of the mitochondrial pyruvate carrier (MPC)! Imagine this: Pyruvate—the key fuel from breaking down carbs—needs a secure shuttle into the mitochondria, our cellular power plants, to crank out ATP, the energy that keeps us alive and thriving. Using cutting-edge cryo-electron microscopy, researchers at the University of Cambridge have mapped this protein at atomic resolution. It operates like a canal lock: gates open and close in perfect sync, escorting pyruvate deep inside without a single leak. Why does this matter? Because controlling this gateway could revolutionize medicine: - Cancer's Achilles' heel: Tumors like prostate cancer overproduce MPC to guzzle pyruvate and grow wildly. Block it? Starve the bad guys while healthy cells adapt. - Hair today, gone tomorrow? Not anymore: Tweaking MPC in hair follicles boosts lactate production, awakening dormant stem cells for potential regrowth therapies. - Beyond that: Tailored drugs for metabolic diseases, diabetes, and neurodegeneration—targeting energy at its root. This isn't just a solved mystery; it's a blueprint for precision medicine. Drug developers, biotech innovators— the era of MPC-targeted therapies is here. Who's ready to turn cellular energy hacks into life-changing treatments? What excites you most: the oncology potential, the hair restoration angle, or something else? Drop your thoughts below! 👇 #BiotechBreakthrough #CancerResearch #PrecisionMedicine #InnovationInHealth #StructuralBiology 📚 Shoutout to the University of Cambridge team | Published in Nature Structural & Molecular Biology | Via ScienceDaily (2025)

🚀 Breaking Down Viral Defenses: A New Frontier in Antibody Therapy & Vaccine Design 🦠💡 Neutralizing antibodies (NAbs)  play a critical role in combating viral infections, guiding both therapeutic strategies and vaccine development. However, viral evolution and immune evasion present ongoing challenges, necessitating a deeper understanding of antibody mechanisms. A groundbreaking study from Yang Huang and colleagues at Xiamen University reveals how a powerful antibody, 7H13, neutralizes #rotavirus (#RV) by exploiting a hidden vulnerability in its VP4 “#spike” protein—a discovery with far-reaching implications for combating viral evolution and designing universal vaccines! Utilizing advanced cryo-electron microscopy (#cryoEM) and cryo-electron tomography (#cryoET), scientists revealed how 7H13 induces irreversible damage to the viral VP4 protein, effectively blocking the virus's adsorption process. Read the full study to dive deeper into this! 🔗 https://lnkd.in/dWv7e4N5 🔑 Insights: 🔍 Broad-Spectrum Power: 7H13 targets a conserved epitope on VP4, enabling neutralization across diverse RV genotypes and protecting mice from infection. 🔍  Essential Structural Insights: Structure-guided mutations confirmed the crucial role of the 7H13 heavy chain I54 in activating the 'molecular switch' of F418 and initiating VP4 disruption. This destabilizes the spike’s meta-stable structure, irreversibly disabling the virus. Cryo-EM’s Crucial Role: 📌 By employing a low-temperature, time-resolved cryo-EM technique, scientists captured a series of intermediate states of viral immune complexes and elucidated the high-resolution structure of the VP4:7H13 complex. 📌 Time-resolved cryo-EM unveiled dynamic, asymmetric antibody binding and intermediate states of viral disruption—a feat impossible with traditional methods. This highlights cryo-EM’s critical role in resolving complex biological mechanisms at near-atomic resolution. 💥 Why This Matters: Viruses like RV rely on dynamic, unstable proteins to invade host cells. By targeting these structural Achilles’ heels, antibodies like 7H13 offer escape-resistant therapies and blueprints for broad-spectrum vaccines and therapeutics against rotaviruses. 🌍 The Bigger Picture: As viral evolution outpaces conventional therapies, understanding how antibodies dismantle pathogens is critical. This work not only expands our toolkit against RV but also sets a paradigm for tackling other viruses—from influenza to coronaviruses—by targeting conserved, conformationally fragile sites. #AntiviralResearch #CryoEM #BroadlyNeutralizingAntibodies #Rotavirus #VaccineDevelopment #StructuralBiology #Biotechnology #HealthcareInnovation

First structural images of a tuberculosis-fighting virus Phage therapies, which use viruses to attack drug-resistant bacteria, are gaining attention as potential alternatives to antibiotics. Because they recognize different aspects of bacteria than typical antibiotics, they may be able to kill pathogens that have evolved to avoid recognition by the standard drugs. But the phages that target Mycobacteria—known as mycobacteriophages—have remained poorly understood. Scientists have had little insight into the phages’ structures and how they recognize and infect Mycobacteria. The research team set to answer these questions and create atomic-level models of the mycobacteriophage known as Bxb1. The team combined data from single particle cryo-electron microscopy (cryo-EM) and cryo-electron tomography (cryo-ET), two imaging techniques that allow researchers to visualize frozen biological structures at near-atomic resolution. They captured images at multiple stages of infection—revealing how Bxb1 attaches to Mycobacteria, injects its genetic material and begins the infection process. The results were surprising. “Other phages form a channel through the bacterial membrane to inject their DNA, so we expected to see the same here,” the author said. “But we didn’t. This suggests mycobacteriophages use a completely different genome translocation mechanism.” Myobacteria have particularly thick and unusual cell walls compared to other bacteria, and the author said more work is needed to uncover how phages are able to inject their genome through this formidable and seemingly impenetrable cell wall. The new structures also revealed how the tail tip of the phage dramatically changed when it bound to the bacteria, providing insights into the dynamic process of infection. The structure contains protein assemblies with 3-, 5-, 6-, and 12-fold symmetries, which interact to satisfy several symmetry mismatches. #ScienceMission #sciencenewshighlights https://lnkd.in/gn2Y4qcJ